Jim Simons In Med Pharmaceuticals Inc. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$0.32 - $0.44 $3,392 - $4,664
-10,600 Reduced 27.25%
28,300 $10,000
Q4 2023

Feb 13, 2024
BUY
$0.33 - $0.99 $12,837 - $38,511
38,900 New
38,900 $16,000
Q1 2023

May 12, 2023
BUY
$1.05 - $2.3 $81,375 - $178,250
77,500 New
77,500 $84,000

Others Institutions Holding INM

# of Institutions
16
Shares Held
463K
Call Options Held
0
Put Options Held
0
View Full List

About InMed Pharmaceuticals Inc.

INM Quotes by TradingView
  • Ticker INM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 908,761
  • Market Cap $218K
  • Description
  • InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...
More about INM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email